News

Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published recently in the Journal of General Internal Medicine, a McGill-led team published the results of a recent survey of 28 experts working in vaccinology.

MeaningCloud announced the completion of it's Artificial Intelligence (AI) businesses into an independent company. This will allow both product and management teams to be more responsive to customers' particular needs and achieve faster growth through focused and fit-for-purpose operating models.

Clinpharm Private Limited partners with Azidus to strategically expand combined services offerings and avail access to an expanded client base for technical requisites of pharmaceutical and biotechnology industries.

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

Women vaccinated against HPV have a significantly lower risk of developing cervical cancer, and the positive effect is most pronounced for women vaccinated at a young age. That is according to a large study by researchers at Karolinska Institutet in Sweden.

Young researchers with an advanced degree can apply for the highly prestigious Eppendorf Award for Young European Investigators that acknowledges outstanding contributions to biomedical research in Europe .

Researchers have discovered a lipid found in the human body that could be used to prevent or treat infections with SARS-CoV-2.

Researchers in the group of Jeroen den Hertog, in collaboration with researchers in Leiden, have found that a compound inhibits a group of proteins called BMP receptors. This compound, called cercosporamide, was previously only known to inhibit a different group of proteins.

Various plants and their products are known to contain "bioactive" ingredients that can alleviate human diseases. These "phytocompounds" often contain restorative biological properties such as anti-cancerous, antioxidant, and anti-inflammatory effects. A team of researchers at Tokyo University of Science has been working this direction for the past several years, to identify novel active components in functional foods and understand their effects on the body.

A Phase III, randomized, double-blinded, placebo-controlled trial will help to determine if the dual-antibody treatment, REGN-COV2, can prevent infection in individuals who share a home with someone who has been diagnosed with COVID-19.